Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onbio is a high-tech biotechnology company specializing in the research, development, and production of core raw materials for molecular diagnostics, next-generation sequencing (NGS), and biopharmaceutical manufacturing. The company provides a wide range of high-performance enzymes, including DNA polymerases and reverse transcriptases, which are essential for PCR, qPCR, and sequencing workflows. Beyond reagents, Onbio offers contract research and manufacturing services (CRO/CDMO) to support the development of diagnostic kits and therapeutic biologics. With a focus on enzyme engineering and large-scale fermentation, the company serves global clients in the life sciences and healthcare sectors. Onbio is also recognized for its contributions to 3D bioprinting technologies through its international branches, providing bio-inks and bioprinting systems for tissue engineering research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onbio.